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Abstract 
 
Introduction  
Single unprovoked seizures occur in about 4% of the population and 
they have significant psychosocial consequences for the patients and 
their families.  Little information is available on the timeliness and safe-
ty of assessment of first unprovoked seizures.  In this study, we review 
the timeliness of the referral and evaluation of patients with first unpro-
voked seizure in a Canadian neurological provincial referral center. 
 
Method  
Retrospective analysis of 51 patients over a 3.5 year period was per-
formed and data were collected on patient demographics, date of 
event and time to evaluation by the epileptologist, evaluations complet-
ed, treatments initiated, and patient outcomes. 
 
Results  
We found that most patients were seen by the epileptologist within 6 
months, there was only a 9% discrepancy in final diagnoses between 
the epileptologist and the referring physician, and there were no fatali-
ties or serious complications in the patients we studied.  However, a 
few patients waited very long periods before imaging and evaluation 
by the epileptologist, and restrictions on driving privileges were recom-
mended in only 3% of the patients. 
 
Conclusions  
We conclude that the referral process for a first unprovoked seizure is 
timely.  Primary care providers need further education with regards to 
the consequences of seizures and some areas of the referral region 
need better access to imaging and epileptologists. 
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Background 
A first unprovoked seizure is a sudden and 
unexpected life-event, occurring in 4% of the 
general population.1  A prospective study 
from Iceland showed a mean annual inci-
dence of 56.8 per 100,000 person-years for a 
first unprovoked seizure.  Of these, 23.5 per 
100,000 person-years had a single unpro-
voked seizure compared with 33.3 per 
100,000 person-years who later developed 
epilepsy.2  The numbers are considered rep-
resentative for most developed countries.  In 
another study,3  the overall incidence of un-
provoked seizures in both children and adults 
in Sweden was 60 per 100,000. 
 
The overall risk of seizure recurrence follow-
ing a single unprovoked seizure ranges from 
27% to 71% .4  The average risk of recur-
rence in a meta-analysis was found to be 
40% in prospective studies and 52% in retro-
spective studies.  The risk of recurrence is 
highest within the first weeks of the first 
seizure and decreases with time, with about 
80% of recurrences occurring within two 
years of the initial seizure.5  
 
Some studies have also shown that people 
with seizures/epilepsy are at high risk of 
premature mortality, with the risk being 
highest at onset of seizures.6  Therefore, 
appropriate and timely assessment and inves-
tigation of these patients is essential in estab-
lishing the etiologies, ruling out treatable 
conditions, and providing appropriate man-
agement especially in those at high risk of 
recurrence.  
 
For the above reasons, there is an urgent 
need to properly assess and manage patients 
after a single unprovoked seizure with the 
goals of establishing the clinical diagnosis; 
determining if the patient has epilepsy by 
ruling out possible underlying etiologies; and 
determining the risk of recurrence, prognosis, 
and the need for antiepileptic medication for 
patients at moderate or high risk of recur-
rence.  Few studies have focused on the con-
sequences of a prolonged waiting time after a 
patient has a single unprovoked seizure.  In 
many countries, the establishment of single 
seizure clinics is a very well recognized 
strategy to improve the early diagnosis and 
treatment of patients with single unprovoked 
seizures.  In Canada, not many provinces 
have single seizure clinics and the majority 
of patients are seen by general practitioners 
or emergency doctors and then referred to 
neurologists.  This delay can have direct 
consequences on the patient such as injuries, 
death, or other potential negative outcomes, 
in addition to the stress and anxiety that pa-
tients can suffer without a proper diagnosis.  
 
The main objective of this study was to in-
vestigate the wait time to completion of med-
ical assessment of single unprovoked seizure 
patients referred to a local epilepsy clinic. 
Another goal was to evaluate the safety of 
the referral and assessment process.  These 
would help determine if wait times for medi-
cal assessment and investigations have any 
impact on the outcomes of first unprovoked 
seizures. 
 
Materials and Methods 
A retrospective chart review from an epilep-
sy clinic run by a single epileptologist was 
performed over a period of 3.5 years (2007 – 
2010).  This is the only available epilepsy 
clinic in the Canadian province of Saskatche-
wan (population of one million), and ascer-
tains patients with all kinds of seizure disor-
ders.  The clinic is located at the University 
hospital, which is the only hospital in the 
province with a certified electroencephalog-
raphy laboratory to investigate patients.  Data 
were collected on all patients referred to the 
epilepsy clinic because of single unprovoked 
seizures.  Initially 70 cases were identified  
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for the said period.  51 of the reviewed charts 
fulfilled the criteria for a single unprovoked 
seizure.  19 were excluded from the study; 
some had presented with a status epilepticus 
and in others, a review of history and hospi-
tal records revealed that they had a prior 
history of seizures or a known seizure disor-
der.  Patients with provoked seizures (known 
cause of seizure, for example metabolic or 
electrolyte disorders) were also excluded.  
Information collected on driving was based 
on review of hospital charts and ambulatory 
care notes written by primary care physicians 
and the patient’s account on whether or not 
counseling regarding driving (including any 
driving restrictions) had been provided.  
Given the retrospective nature of this study, 
the motor vehicle licensing department could 
not be contacted without informed consent 
for verification. 
 
 
Data gathered included: Age of patient, date 
of single seizure/spell, date of initial assess-
ment, the initial assessment and impression, 
specialty of physician performing initial 
assessment, date of referral to the epileptolo-
gist, date seen by epileptologist and wait 
times for imaging, computed tomography 
(CT) and magnetic resonance imaging (MRI) 
of the brain and electroencephalogram (EEG) 
from time of event. Median and mean wait 
times were determined and the final diagno-
sis by the epileptologist was compared to the 
initial impression of the referring physician.  
Seizure recurrence during the wait times or 
during the assessment period was considered 
a major adverse event and associated injuries 
were classified as minor if they resulted in no 
substantial bodily harm (bruising, etc.) re-
quiring no medical attention or treatment and 
as major if bodily harm (fractures, etc.) was 
obvious requiring medical attention.  Apart  
3
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from the above, other safety variables includ-
ed abnormal EEG and abnormal MRI find-
ings considered predictive of a higher risk of 
seizure recurrence.  Microsoft Excel and 
SPSS software were used to analyze collect-
ed data. For the diagnosis of epilepsy, we 
used the new definition by the International 
League Against Epilepsy (ILAE),7 which 
requires the occurrence of at least one sei-
zure.  All the cases were investigated with 
EEG, CT, and/or MRI.  This study represents 
a pilot study trying to obtain evidence for the 
establishment of single seizure clinics in 
Canada and other countries.  
 
Results 
Fifty-one patients were included.  Median 
age at single seizure was 41 years (range 16– 
 
81).  The sex distribution was 51.9% (28) 
male and 48.1% (23) female.  Figure 1 shows 
the distribution of events across the different 
age groups. 
 
The description of the spell was consistent 
with seizure in 90.7% (48), syncope in 3.9% 
(2), and migraine variant in 1.9% (1) of cas-
es.  The three seizure types described were 
generalized tonic-clonic seizures (grand mal) 
in 93.8% (45), complex partial seizures in 
4.2% (2), and tonic seizures in 2.1% (1) of 
presumed seizures. 
 
Wait times for investigations and the epilep-
tologist are shown in Figure 2.  Median wait 
times to see the epileptologist were one 
month from either time of single seizure or 
time of referral.  54.9% of patients were seen  
 
Figure 2: Wait times for investigations and epileptologist (initial event versus referral) 
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within 2 months and 98.5% were seen within 
6 months of initial event by the epileptolo-
gist.  
 
The median wait time for EEG was 1.5 
months (0 – 14.5); 59.6% of the EEGs were 
performed within 2 months and 75% within 7 
months from the initial event.  Mean wait 
time for head CT scan was 5 months (0 – 
22); 55% of these were performed within 48 
hours of the event.  Median waiting time for 
brain MR-imaging was 5 (0 - 36) months; 
59.3% of MRIs were completed within 6 
months of event. 
 
The initial assessment was performed in 
42.6% by an ER physician, 25.9% by a fami-
ly physician, 7.4% by an internist, and 14.8% 
by a general neurologist.  In 3.7% of cases  
 
the specialty of the initial assessing physician 
was unknown.  
 
Figure 3 shows the median wait times to see 
the epileptologist as a function of the refer-
ring physician.  Patients referred by either an 
emergency physician or an internist had the 
shortest median wait times, while those re-
ferred by another neurologist had the longest 
wait times. 
 
The diagnosis of seizure disorder by the 
epileptologist differed only by 9% from the 
original assessment performed by the refer-
ring physician, representing a high degree of 
convergence (91%).  Of all 51 cases re-
viewed, 4 diagnoses were altered after as-
sessment by the epileptologist.  Two cases 
previously considered possible syncopes  
5
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were diagnosed with primary generalized 
epilepsy.  One diagnosis of possible migraine 
was changed to primary generalized epilep-
sy, and one diagnosis of seizure disorder was 
inconclusive (possible migraine variant).  
The latter was not excluded from the study. 
 
Anti-epileptic medication was initiated in 
20.4% of patients prior to referral.  Most 
frequently used antiepileptic drugs (AEDs) 
were phenytoin (33%) and lamotrigine 
(27.8%).  The decision to treat was attributed 
to: concerns for seizure recurrence in 16.7%, 
EEG abnormalities in 18.5%, abnormal im-
aging findings in 13%, and other reasons in 
51.8%.  The reasons for starting AEDs are 
shown on table 1.  
 
A positive family history of seizures was 
reported in 22.2% (12 patients), childhood 
seizures and/or febrile seizures in 9.3% (n = 
5), history of head trauma and/or central 
nervous system (CNS) infections in 14.8 % 
(n = 8).  Alcohol and illicit drugs were con-
sidered possible triggers in 7.4% and 3.7% of 
cases, respectively. 
 
 
 
 developmental delay (1) 
 violent seizure (1) 
 history of head injury - not seizure related (1) 
 unknown (5) 
Reason # of cases 
EEG abnormalities 10 
MRI abnormalities 2 
CT abnormalities 5 
Seizure recurrence 9 
Other reasons* 13 
Table 1: Reasons for initiating AEDs after 1st unprovoked seizure  
 
Seizure recurrence was noted in 25.5% (13 
of 51) after a follow-up of at least 12 months. 
46.2% of these patients showed imaging 
abnormalities while 38.5% had abnormal 
EEG findings.  29% of patients started on 
AEDs had both abnormal EEG and imaging 
findings, 29% had abnormal EEG only, and 
19.5% had abnormal imaging only.  Seizure 
recurrence was 28.2% (11 of 39) in patients 
with normal CT head and 16.7% (2 of 12) in 
patients with structurally abnormal CT head. 
Normal and abnormal EEGs were associated 
with recurrence rates of 26.7% and 23.8%, 
respectively.  The EEGs of two patients with 
focal slowing were considered abnormal, al-
though no other epileptiform features were 
observed.  Abnormal MR-imaging was asso-
ciated with a recurrence rate of 25% (4 of 
16), and in those with both abnormal MR-
imaging and EEG, the recurrence rate was 
only 10% (1 of 10).  Table 2 shows the dif-
ferent EEG patterns (patients who had more 
than one EEG are also included).  Figure 4 
shows the distribution of seizure recurrence 
across the different age sub-groups. 
 
 
*Other reasons (n=13): 
 
 job as fireman (1) 
 desire to resume driving (2) 
 two generalized tonic-clonic seizures in 24 hours 
(2) 
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EEG findings Frequency 
1 
  
Spikes Generalized spike and wave 11 
Right temporal spikes 1 
Right frontal spikes 2 
Bilateral temporal spikes 2 
2 Slowing Left TIRDA 1 
Right frontal slowing 1 
Left temporal slowing 1 
Generalized slowing 2 
3 Other patterns Breach rhythm 2 
Triphasic waves 1 
4 Normal 29 
Table 2: EEG findings and distribution of documented abnormalities  
        EEG report missing in one case 
 
Figure 4: Seizure recurrence rates in different age groups  
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Seizure recurrence rates were: 40% (2 of 5) 
in patients with a past history of febrile or 
childhood seizures, 25% (2 of 8) in those 
with a prior history of CNS infection or head 
trauma, and 41.7% (5 of 12) in those with a 
positive family history of seizure disorder. 
The rate was 20.5% (8 of 39) in patients with 
a negative family history of seizure disorder. 
Seizures recurred in 50% (2 of 4) if the initial 
event was related to illicit drug use or alco-
hol intoxication.  
 
During the waiting period, minor injuries 
(bruising) were reported in two patients; 
there were no reported mortalities.  Formal 
documentation on counselling about driving 
restrictions and reporting of patients follow-
ing seizure or seizure-like events by primary 
care physicians to the driver’s licensing au-
thority as mandated by provincial legislation 
in the province of Saskatchewan could only 
be found in 3% of cases.  
 
Discussion 
We found that 98.5% of patients in the dis-
trict were seen by the epileptologist within 6 
months and that during the waiting period 
there were no case fatalities, and only 2 cases 
of minor seizure-related injuries (due to sei-
zure recurrence).  These findings suggest that 
patient referral and assessment is being done 
in a safe and relatively timely fashion given 
the otherwise long wait times for neurolo-
gists in the province.  We consider the wait 
time from time of event to time the patient 
was seen by the specialist to be excessively 
long, not albeit comparable to the data from 
the National Clinical Audit of epilepsy-
related death from the UK,8 where only 69% 
of referrals were completed within 1 week 
and 15% of individuals had to wait more 
than 6 months for specialist appointments. 
The delay in the referral process is reflected 
in our study and some cases with extremely 
long wait times from time of event could be 
attributed to lack of knowledge about the 
referral process by primary care physicians 
or an attempt to manage by same.  The estab-
lishment of a first seizure clinic with clear 
referral guidelines would reduce this unnec-
essary delay and make the process more 
efficient and safer.  The National Clinical 
Audit of epilepsy-related death by the Na-
tional Institute for Clinical Excellence 
(NICE) in the United Kingdom8 showed that 
wait times for specialist appointment after 
first seizures were long, with 15% of patients 
waiting more than 6 months.  Based on this 
audit, they recommended an urgent follow-
up by an epilepsy specialist ideally within 2 
weeks for all patients with first seizure.  Wait 
times longer than 2 weeks are therefore con-
sidered long based on the NICE recommen-
dations. 
 
Seizure recurrence was highest in the age 
group younger than 20 years and also slightly 
higher in those older than 70 years.10  This 
finding is similar to that reported in the UK 
National General Practice Study of Epilepsy, 
with highest recurrence in patients under the 
age of 16 and those older than 59 years.11 
Early seizure frequency, etiology of seizures, 
and an abnormal EEG are known to be pre-
dictive factors for seizure recurrence12 and 
long term outcomes as observed in the MESS 
trial13 and a long term follow-up study14; 
recurrence in our study was altered by the 
early use of AEDs in patients with abnormal 
EEGs and/or abnormal MRIs.  The high rate 
of neuroimaging and EEG abnormalities in 
this study most likely reflects the highly 
selective nature of the group; considered 
high risk for seizure recurrence or likely 
focal seizure in origin, as not all patients with 
first unprovoked seizures are referred to the 
epileptologist in the province of Saskatche-
wan. 
 
The occurrence of single unprovoked sei-
zures has psychosocial implications for pa-
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tients and families, and concerns about etiol-
ogy and likelihood of recurrence often im-
pact life-style areas such as driving re-
strictions and restrictions in work, family, 
and leisure activities.15  Although in this 
study there was no reported mortality or 
major injuries from the event or subsequent 
recurrence, the professional, financial, and 
psychosocial impact cannot be underestimat-
ed and patients probably have to be assessed 
in well-organized single seizure clinics.  
 
There was a substantial delay in obtaining 
even basic imaging (CT head) with only 50% 
scanned within 24 hours, most likely due to 
unavailability of scanners in some parts of 
the province.  Retrospective, prospective, 
and randomized controlled studies in both 
adults and children have provided data show-
ing that early seizure recurrence is reduced 
by early initiation of anticonvulsant treat-
ment, but this intervention does not alter the 
prognosis for the development of epilepsy.16 
The risk of recurrence is increased with ab-
normal imaging, epileptiform changes on 
EEG, positive family history of epilepsy, and 
remote symptomatic seizures.9  These factors 
might increase the likelihood of AED use 
after a single event, reflecting the reasons for 
the early initiation of AED in our patients. 
Although the American Academy of Neurol-
ogy does not recommend treatment with 
AED for the prevention of the development 
of epilepsy following first unprovoked sei-
zure (level B), the guidelines suggest consid-
ering the use of AEDs where the benefits of 
second seizure risk reduction outweigh the 
risk of pharmacologic and psychosocial side 
effects.  Overall, AEDs were started in 
74.1% of first unprovoked seizure (only 25% 
recurrence rate in this subgroup).  About 
20% of these cases were started on AEDs by 
the primary care physician; the overall use of 
AED is higher than would be expected, but 
this is not different from that reported by 
Hauser, et al.4  A possible explanation would 
be that the cases referred to the epileptologist 
represent higher risk patients when compared 
to the general population of patients with 
single unprovoked seizures.  This is further 
supported by the high incidence of EEG and 
imaging abnormalities in this study.  A good 
number of those patients with abnormal im-
aging or EEG findings were started on 
AEDs.  This is the most likely explanation 
for the lower rate of seizure recurrence in this 
group.  Consequently, as previously reported 
in other studies, we consider abnormal EEG 
to be a good predictor of seizure recurrence, 
but it might have been masked in this study 
by the early use of AEDs.  In our study, pre-
dominantly first generation antiepileptic 
drugs were used: phenytoin and lamotrigine. 
 
The low rate of reported driving restrictions 
by the primary care physician shows lack of 
awareness and probably lack of knowledge 
about the implications of a single seizure. 
This aspect has to be improved in a province 
like Saskatchewan where a mandatory writ-
ten report to Saskatchewan Government 
Insurance (SGI) is required after a seizure.  A 
better education of family practitioners and 
ER physicians about the social, occupational, 
and health implications of a single unpro-
voked seizure is required in the future.  Es-
tablished single seizure clinics also can im-
prove proper driving restrictions and avoid 
the possibility of accidents in patients.     
 
There are some limitations: our study was a 
retrospective chart review that only captured 
patients referred to the epileptologist, and as 
such does not reflect the outcome of those 
patients referred to other neurologists or 
physicians in Saskatchewan.  Moreover, the 
wait times were calculated from the date of 
initial event or referral until the date of as-
sessment or date on which the test was per-
formed, and we did not take into considera-
tion if any previous appointments were 
missed by the patient.  A potential limitation 
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of our study could be the sample size,          
although the age of our cohort, the recurrence 
rate, and other outcomes are similar to other 
epidemiological studies with single unpro-
voked seizures performed in other countries. 
 
Conclusions 
 
We conclude that the regional referral pro-
cess of patients with a single unprovoked 
seizure is timely.  Although there were no 
case fatalities, due to the limitations of this 
study as mentioned above, safety issues need 
to be addressed in a prospective study.  The 
wait times are longer than we had expected 
and the process is slower than recommended 
in most guidelines.  This situation could be 
similar in other Canadian centers, where 
patients are not seen immediately and wait 
substantial time to get fully investigated.  
Education of primary care physicians is im-
portant to avoid unnecessary delays and 
mismanagement of patients.  Further im-
provements are needed to increase access to 
investigations (especially EEG, CT, and 
MRI) with the ultimate goal of maximizing 
diagnostic yield and hence, the ability to 
stratify the patients for risk of seizure recur-
rence.  We suggest the establishment of a 
first/single seizure clinic as well as clear 
referral guidelines as the best approach for 
these patients.  To our knowledge this is the 
first study in the literature reporting wait 
times after single unprovoked seizures. 
 
A larger study (preferably, a prospective 
study with direct recruitment of patients from 
the emergency departments) involving sever-
al referral centers is necessary to evaluate the 
timeliness and safety of referrals of first 
unprovoked seizures.  
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